Jae-Joon Kim
Director/Board Member at YOUCEL, Inc.
Net worth: 468 628 $ as of 30/04/2024
Profile
Jae-Joon Kim currently works at Mirae Asset Venture Investment Co., Ltd., as Senior Managing Director, ImmunoMet Therapeutics, Inc., as Director from 2016, and YOUCEL, Inc., as Non-Executive Director.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2023 | 114,030 ( 0.21% ) | 468 628 $ | 30/04/2024 |
Jae-Joon Kim active positions
| Companies | Position | Start |
|---|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
 Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ (Mirae Asset Venture) is a private equity & venture capital subsidiary of Mirae Asset Venture Investment Co., Ltd. founded in 1999. The firm is headquartered in Seongnam, South Korea with an office in Seoul. | Private Equity Investor | 01/01/2018 |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Director/Board Member | 01/03/2016 |
YOUCEL, Inc.
 YOUCEL, Inc. BiotechnologyHealth Technology YOUCEL, Inc. engages in the manufacture and sale of cosmetics and pharmaceutical products. Its products include facial masks, cleansers, and hair and skin care products. The company was founded on August 18, 2008 and is headquartered in Iksan-si, South Korea. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ (Mirae Asset Venture) is a private equity & venture capital subsidiary of Mirae Asset Venture Investment Co., Ltd. founded in 1999. The firm is headquartered in Seongnam, South Korea with an office in Seoul. | Finance |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
YOUCEL, Inc.
YOUCEL, Inc. BiotechnologyHealth Technology YOUCEL, Inc. engages in the manufacture and sale of cosmetics and pharmaceutical products. Its products include facial masks, cleansers, and hair and skin care products. The company was founded on August 18, 2008 and is headquartered in Iksan-si, South Korea. | Health Technology |
- Stock Market
- Insiders
- Jae-Joon Kim
